ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2417

Is Remission Really Achievable in EARLY Rheumatoid Arthritis?

Olga Addimanda1, Pierluigi Macchioni2, Andrea Caruso1, Niccolò Possemato1, Mariagrazia Catanoso1 and Carlo Salvarani2, 1S.C. Reumatologia, Arcispedale Santa Maria Nuova, I.R.C.C.S., Reggio Emilia, Italy, 2Rheumatology Unit, Arcispedale S Maria Nuova, Reggio Emilia, Italy

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Clinical Response, Early Rheumatoid Arthritis, remission and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Session Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose: : to stress the need of routine use of US imaging in treat to target strategies aiming to achieve remission in early rheumatoid arthritis.

Methods: 54 patients with early rheumatoid arthritis (ERA) or undifferentiated arthritis (UA) diagnosed according to 2010 ACR/EULAR criteria were enrolled. Demographic (age, gender, disease duration,BMI), clinical (total SJC and TJC, DAS28, CDAI, SDAI, HAQ, EULAR response), serological (ESR, CRP, RF, anti-CCP) data has been collected. Ultrasonographic hand (MCP, PIP and DIP joints), wrists (intercarpic and radiocarpic joints) and feet ( MTP, PIP, DIP as well as ankle joints) evaluation was performed according to OMERACT recommendations. The patients were evaluated at baseline, after three and six months:all 54 patients have complete 3rd month follow-up data, only 38 have already completed 6th month follow-up.

Results: 11 UA (20,4%) and 43 RA (79,6%) were enrolled from November 2012 to January 2014.Mean disease duration was 15,5 ± 7,8 weeks (min – max 4 – 24).  26  (48,1%) were RF positive (Mean ± sd values 121.7 ± 90.5 ) and 25 (46,3%) were CCP positive (Mean ± sd values 361,0 ± 448,2).  Only 8 (14,8%) showed radiographic erosions at baseline.We observed a progressive reduction in all clinical and clinimetric features not associated with statistically significant improvement in US findings (Table). When analyzing for predictive factors of good response only increased values of ESR and CRP at baseline were found to be associated with better clinical response altough not always reaching statistically significant value (ESR t0-t3 p = 0,024; ESR t0-t6 p = 0,766; CRP t0-t3 p = 0,822; CRP t0-t6 p = 0,071). Baseline number of joints with US synovitis or power-Doppler (PD) signal were not different between responder and not responder at 3 and 6 months. The number of joints with US synovitis or US presence of PD were not statistical different between moderate or good responder at 6 months.

Conclusion: clinical remission could not be considered enough to avoid erosive progression in rheumatoid arthritis and US remission is needed in order to avoid structural damage

Table. Clinical and US features

 

 

Baseline

(A)

T-3

(B)

T-6

(C)

P value

(A vs B)

P value

(B vs C)

CLINICAL FEATURES

DAS28

5,2 ± 1,3

2,3 ± 0,8

1,3 ± 1,0

<0,0005

<0,0005

REMISSION

n° of pts

(%)

3/54

(5,6)

22/54

(40,7)

11/38

(28.9)

<0,0005

<0,0005

LDA

n° of pts

(%)

1

(1,9)

6

(11,1)

9/38

(23.7)

<0,0005

<0,0005

MDA

n° of pts

(%)

26

(48,1)

18

(33,3)

14/38

(36.8)

<0,0005

<0,0005

HDA

n° of pts

(%)

24

(44,4)

5

(9,3)

4/38

(10.5)

<0,0005

<0,0005

EULAR RESPONSE

GOOD

n° (%)

/

24/54

(44.4)

20/38

(52.6)

 

 

MODERATE

n° (%)

/

24/54

(44.4)

17/38

(44.7)

 

 

NO RESPONSE

n° (%)

/

3/54

(5.6)

1/38

(2.6)

 

 

US FEATURES

SYNOVITIS

n° of pts

(%)

46/54

(85.2)

38/54

(70.4)

33/35

(94.3)

n.s. (0.743)

n.s. (0.803)

POWER-DOPPLER

n° of pts 

(%)

40/54

(74.1)

30/54

(55.6)

27/35

(77.1)

n.s. (0.097)

n.s. (0.324)

EROSIONS

n° of pts

(%)

15/54

(27.8)

17/54

(31.5)

14/35

(40.0)

<0.0005

<0.0005


Disclosure:

O. Addimanda,
None;

P. Macchioni,
None;

A. Caruso,
None;

N. Possemato,
None;

M. Catanoso,
None;

C. Salvarani,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-remission-really-achievable-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.